SCIENCE NEWS Bioactive Peptides Found to Promote Wound Healing Newly-created bioactive peptides, produced from collagenase treatment of extracellular matrix, promote wound healing through the growth of new blood vessels and epithelial tissue. [Press release from The Tufts Center for Innovations in Wound Healing Research discussing online prepublication in Wound Repair and Regeneration]
|
|
CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal) Beta-Catenin Mediates Mechanically Regulated, Transforming Growth Factor-Beta1-Induced Myofibroblast Differentiation of Aortic Valve Interstitial Cells Myofibroblast differentiation of valve interstitial cells involves matrix stiffness-dependent crosstalk between TGF-1 and Wnt signaling pathways and may explain in part why the stiffer fibrosa is more susceptible to disease. [Arterioscler Thromb Vasc Biol] Mechanics of Cell Spreading Within 3D-Micropatterned Environments Findings highlight the dynamic relationship between cellular forces and acto-myosin contractility in 3D environments, the influence of cytoskeletal network mechanics on cell shape, as well as the importance of cell-extracellular matrix contact area in the generation of traction forces. [Lab Chip] Structural Diversity in Integrin/Talin Interactions Researchers employed NMR to probe interactions and dynamics, revealing marked structural diversity in the contacts between beta1A, beta1D, and beta3 tails and the Talin1 and Talin2 isoforms. [Structure] The Disintegrin-Like and Cysteine-Rich Domains of ADAM-9 Mediate Interactions Between Melanoma Cells and Fibroblasts Results suggest that ADAM-9 expression plays an important role in mediating cell-cell contacts between fibroblasts and melanoma cells and that these interactions contribute to proteolytic activities required during invasion of melanoma cells. [J Biol Chem] Networked-Based Characterization of Extracellular Matrix Proteins from Adult Mouse Pulmonary and Aortic Valves This study reports the healthy adult pulmonary and aortic valve proteomes characterized by LC/MS/MS, resulting in 2710 proteins expressed by 1513 genes, including over 300 abundant extracellular matrix proteins. [J Proteome Res] Biomimetic Hydrogels with Vascular Endothelial Growth Factor Induce Angiogenic Processes in Both hUVEC and hMEC The goal of the current study was to develop a system with a backbone of polyethylene glycol and grafted angiogenic signals to compare the initial angiogenic response of human umbilical vein endothelial cells (hUVEC) or human microvascular endothelial cells (hMEC). [Biomacromolecules] Functional Composite Nanofibers of Poly(Lactide-Co-Caprolactone) Containing Gelatin-Apatite Bone Mimetic Precipitate for Bone Regeneration Based on these results, the gelatin-apatite-poly(lactic-co-caprolactone) composite nanofiber developed in this study is considered to be potentially useful as a bone tissue regeneration matrix. [Acta Biomater] Biological Hydrogel Synthesized from Hyaluronic Acid, Gelatin and Chondroitin Sulfate by Click Chemistry In order to mimic the natural cartilage extracellular matrix, which is composed of coreproteins and glycosaminoglycan, a biological hydrogel was synthesized from biopolymers of hyaluronic acid, chondroitin sulfate and gelatin via click chemistry. [Acta Biomater] Beta-Radiation Reduces the Reactivity of Extracellular Matrix Proteins in Intravascular Brachytherapy (IVBT), Resulting in Decreased Platelet Adhesion 20-Gy beta radiation significantly decreased platelet adhesion to extra cellular matrix protein vWF and collagen Type III and had no effect on the adhesion upon fibrinogen and fibronectin. [Int J Cardiol] Extracellular Matrix of Collagen Modulates Intracellular Calcium Handling and Electrophysiological Characteristics of HL-1 Cardiomyocytes with Activation of Angiotensin II Type 1 Receptor The study demonstrates that collagen can directly modulate the calcium dynamics and electrical activities of atrial cardiomyocytes, which are associated with the renin-angiotensin system. [J Card Fail] Bioactive Peptides Derived from Vascular Endothelial Cell Extracellular Matrices Promote Microvascular Morphogenesis and Wound Healing In Vitro Researchers postulated that matrix degradation by Clostridial collagenase creates bioactive fragments that can stimulate cellular responses to injury and angiogenesis. [Wound Repair Regen]
|
|
INDUSTRY NEWS Halozyme Announces Roche Completes Patient Enrollment in Phase III Clinical Trial with Subcutaneous Herceptin® Halozyme Therapeutics, Inc. announced that Roche has completed patient enrollment for the pivotal Phase III study of Herceptin SC (trastuzumab subcutaneous), a subcutaneous formulation that uses Halozyme’s Enhanze™ technology (rHuPH20, recombinant human hyaluronidase). [Halozyme Therapeutics, Inc. Press Release] Audax Medical Gains Rights to Brown Regenerative Nanotech Medical device startup Audax Medical Inc. has gained exclusive rights from Brown University for Arxis, a biomaterial intended to help regenerate diseased bone and cartilage, the company reported. [Mass High Tech] WFUBMC Orthopaedic Researchers Awarded DOD Grant Orthopaedic researchers at Wake Forest University Baptist Medical Center (WFUBMC) have been awarded a $2.24 million four-year grant from the U.S. Department of Defense (DOD) to study the use of keratin gel in the regeneration of damaged peripheral nerves, those in the hands, arms and feet. [Wake Forest University Baptist Medical Center Press Release] Histogen Announces Completion of Series A Financing Histogen, Inc. announced the successful completion of its Series A financing at $10 million. [Histogen, Inc. Press Release] Nanoink Launches New Application for Single Cell Arrays at ASCB Annual Meeting NanoInk’s NanoFabrication Systems Division is pleased to announce the launch of a new application for single cell studies that enables micropatterning of proteins and polyethylene glycol-based hydrogel at sub cellular scales. [NanoInk, Inc. Press Release] Orthovita Receives FDA Clearance for Vitoss™ Bioactive Foam-2X Bone Graft Substitute Orthovita, Inc. announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities. [Orthovita, Inc. Press Release] Halozyme Therapeutics Realigns Management Halozyme Therapeutics, Inc. announced the appointment of Gregory I. Frost, Ph.D., to serve as president and CEO, effective immediately. [Halozyme Therapeutics, Inc. Press Release] BioStorage Technologies Expands Global Cold Chain Logistics and Transport Offering to Include Sample Relocation Services BioStorage Technologies, a global leader in scientific asset management, cold chain logistics and biomaterial storage for the bioscience industry, has expanded its service offerings to include a suite of global sample relocation services [BioStorage Technologies, Inc. Press Release]
|
|
EVENTS (Listed by Date) 4th International Conference on the Mechanics of Biomaterials and Tissues December 11-14, 2010 Waikoloa, Hawaii The American Society for Cell Biology 50th Annual Meeting December 11-15, 2010 Philadelphia, United States Pharmacology in Stem Cells Research and Regenerative Medicine December 17, 2010 London, United Kingdom The 3rd Guangzhou International Conference on Stem Cell Biology and Regenerative Medicine December 17-19, 2010 Guangzhou, China Keystone Symposia: Epithelial Plasticity and Epithelial to Mesenchymal Transition January 21-26, 2011 Vancouver, Canada Extracellular Matrix and Cardiovascular Remodeling January 23-28, 2011 Tahoe City, United States 5th Annual Stem Cells and Regenerative Medicine World Congress January 24-25, 2011 San Diego, United States BIO Asia International Partnering Conference January 24-25, 2011 Tokyo, Japan Phacilitate 7th Annual Cell & Gene Therapy Forum 2011 January 24-26, 2011 Washington, D.C., United States IQPC’s 4th Biobanking Conference January 24-26, 2011 Philadelphia, United States AACR-ACS Joint Meeting on Chemistry in Cancer Research: The Biological Chemistry of Inflammation as a Cause of Cancer January 30-February 2, 2011 San Diego, United States Molecular Medicine Tri-Conference: Stem Cells – Revolutionizing Regenerative Medicine and Personalized Therapy 2011 February 23-25, 2011 San Francisco, United States Cell Culture World Congress 2011 – Optimising Cell Culture Development for Biopharmaceutical, Bioprocessing and Manufacture February 28-March 2, 2011 Munich, Germany PITTCON Conference & Expo 2011 March 13-18, 2011 Atlanta, United States 15th Annual Hilton Head Workshop – Regenerative Medicine, Innovations for Clinical Applications March 16-19, 2011 Hilton Head Island, United States United Kingdom National Stem Cell Network 2011 Annual Scientific Conference March 30-April 1, 2011 York, United Kingdom World Stem Cells & Regenerative Medicine Congress 2011 May 9-11, 2011 London, United Kingdom 13th Annual C21 BioVentures May 24-26, 2011 Napa, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community. JOB OPPORTUNITIES Lab Technologist – Cell Separation (STEMCELL Technologies) Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies) Lab Technologist – Tissue Culture (STEMCELL Technologies) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost. Visit here to post your career opportunities.
Have we missed an important article or publication in Extracellular Matrix News? Click here to submit! |
|
|
|